Part AOutcome blind

Capital Allocation · Decision packet

Danaher portfolio and acquisition decision at May 2015

Should Danaher pursue Pall while preparing to separate its industrial portfolio, pursue only one leg of that strategy, or continue its existing bolt-on model?

Knowledge cutoffMay 11, 2015 at 3:59 AM

Decision: May 11, 2015
Knowledge cutoff: May 10, 2015, 11:59:59 p.m. ET

This packet is outcome-blind. It contains no sale rumor, offer, signed transaction term, closing event, or later separation outcome.

Recommendation

Pursue Pall diligence and negotiation while preparing an industrial-separation plan, but authorize neither closing nor separation until independent gates establish price discipline, financing resilience, recurring-revenue quality, customer-safe integration, and tax and operational separation readiness. This is a staged recommendation, not a forecast that both legs will close. judgment.danaher.cutoff.conditional-acquire-separate

No target price, purchase multiple, return, or accretion estimate is presented. Consideration, financing terms, pro forma capitalization, deal-specific synergies, and approved accounting adjustments are missing. Warren therefore abstains from a transaction valuation. assumption.danaher.cutoff.financing-capacity

Reference class

Danaher described DBS as a set of growth, lean, and leadership processes spanning quality, delivery, cost, and innovation, and said acquisition integration affects growth and operating results. That description supports an operating capability; it does not prove that every target or price works. claim.danaher.cutoff.dbs-acquisition-system evidence.danaher.cutoff.dbs-strategy

A contemporaneous publication summarized BCG's successful-serial-acquirer work around investment thesis, network, culture, and process. It is a secondary summary, not a Danaher-specific base rate and not causal evidence for this transaction. claim.reference.cutoff.serial-acquirer-context @src.manager.cutoff.serial-acquirers

Business model and portfolio fit

Pall served Life Sciences and Industrial filtration, separation, and purification markets. The mix gives Danaher a plausible science adjacency but also leaves industrial exposure that complicates a pure science-portfolio thesis. claim.pall.cutoff.business-fit table.pall.cutoff.2014-segment-sales

DBS transferability is an assumption. The acquisition case must preserve technical expertise, regulated-product quality, customer continuity, innovation, and retention rather than treating cost reduction as the sole integration objective. assumption.danaher.cutoff.dbs-transferability

Financial reconstruction

Danaher reported 2014 sales of USD 19.9138 billion and operating profit of USD 3.4313 billion, versus USD 19.1180 billion and USD 3.2749 billion in 2013. The figures are as reported and are not adjusted for perimeter effects. table.danaher.cutoff.annual-performance

Danaher reported USD 3.7584 billion of continuing-operations cash flow and USD 3.1309 billion of cash paid for acquisitions in 2014. This demonstrates acquisition capacity and material reliance on continued capital-allocation execution. claim.danaher.cutoff.acquisition-capacity-intensity table.danaher.cutoff.cash-generation-allocation

Pall reported first-half fiscal 2015 sales of USD 1.370286 billion and net earnings of USD 172.672 million, compared with USD 1.306748 billion and USD 155.179 million in the prior-year period. Different fiscal calendars and segment definitions prevent a simple Danaher-to-Pall margin comparison. claim.pall.cutoff.recent-performance table.pall.cutoff.six-month-performance

Reported Danaher segment growth separately identified existing-business, acquisition, divestiture, and currency components. Any underwriting agent must retain those perimeter limits and must not label headline growth as DBS-created organic growth. claim.danaher.cutoff.perimeter-comparability table.danaher.cutoff.q1-segments

Liquidity and financing

At April 3, 2015, Danaher reported USD 2.5110 billion of cash, USD 123.7 million of notes payable and current debt, and USD 3.0538 billion of long-term debt. These balances support diligence, not an unconditional close: transaction size, commitments, maturities, ratings, covenants, and downside liquidity remain unknown. table.danaher.cutoff.liquidity

Pall reported USD 1.029673 billion of cash, USD 724.796 million of notes payable, and USD 375.342 million of long-term debt at January 31, 2015. Its first-half treasury-stock purchases exceeded reported operating cash flow, a capital-allocation fact that should not be mistaken for recurring acquisition funding. claim.pall.cutoff.balance-and-capital-allocation table.pall.cutoff.liquidity table.pall.cutoff.h1-cash-allocation

Competitive position

The filings support filtration adjacency and recent Life Sciences and Industrial profitability, but do not provide product-level retention, installed-base economics, switching costs, price-cost history, market shares, or customer workflow data sufficient to validate the strongest moat claims. claim.pall.cutoff.business-fit table.pall.cutoff.h1-segments

Pall itself warned that acquisition competition, financing, integration delays, and unrealized efficiencies or synergies can damage results. Deal-specific diligence must therefore remain separate from confidence in Danaher's generic playbook. claim.pall.cutoff.integration-risk conflict.danaher.cutoff.system-versus-deal-specific-risk

Strongest disconfirming evidence

  • Danaher was already deploying capital into bolt-ons; the first quarter included USD 488 million of cash consideration for three businesses. claim.danaher.cutoff.recent-bolt-ons
  • Pall includes substantial industrial exposure, so an acquisition and an industrial separation may create overlapping execution demands. claim.pall.cutoff.business-fit
  • Historical cash generation does not establish resilience under an unknown purchase price and funding structure. conflict.danaher.cutoff.capacity-versus-resilience
  • Reported growth changes with acquisitions, divestitures, currencies, and reporting perimeters. claim.danaher.cutoff.perimeter-comparability

Decision gates

The board should treat the recommendation as four reversible gates:

  1. Price and return: no bid above the approved downside return ceiling.
  2. Financing: no close below approved liquidity, covenant, rating, or refinancing headroom.
  3. Integration: no irreversible operating changes before recurring revenue, quality, retention, and technical-talent baselines are verified.
  4. Separation: no execution before tax, stranded-cost, governance, systems, customer, and employee workstreams pass.

The default on a failed gate is to stop, reprice, defer one leg, or return to smaller bolt-ons—not to manufacture a target price from missing inputs. judgment.danaher.cutoff.conditional-acquire-separate

As reported at the cutoff

Financial and operating evidence

10 tables

Values are carried from the checked research packet with their original units, periods, scope, and reporting status. “Not established” is preserved rather than estimated.

Danaher consolidated performanceAs Reported At Cutoff · USDm
Measure20132014
Sales19,118119,913.81
Operating profit3,274.913,431.31
USD · USDmReported values remain strings; no browser-side recalculation.
Danaher 2014 cash generation and acquisition spendingAs Reported At Cutoff · USDm
Measure2014
Operating cash flow from continuing operations3,758.41
Cash paid for acquisitions3,130.91
USD · USDmReported values remain strings; no browser-side recalculation.
Danaher 2014 selected segment economicsAs Reported At Cutoff · USDm
Measure2014
Life Sciences and Diagnostics sales7,185.71
Life Sciences and Diagnostics operating profit1,105.91
Industrial Technologies sales3,525.81
Industrial Technologies operating profit801.31
USD · USDmReported values remain strings; no browser-side recalculation.
Danaher reported cash and debtAs Reported At Cutoff · USDm
MeasureDecember 31 2014April 3 2015
Cash and equivalents3,005.612,5111
Notes payable and current debt71.91123.71
Long-term debt3,401.513,053.81
USD · USDmReported values remain strings; no browser-side recalculation.
Danaher first-quarter 2015 selected segment economicsAs Reported At Cutoff · USDm
MeasureQ1 2015
Life Sciences and Diagnostics sales1,695.71
Life Sciences and Diagnostics operating profit215.51
Industrial Technologies sales834.51
Industrial Technologies operating profit205.21
USD · USDmReported values remain strings; no browser-side recalculation.
Pall fiscal 2014 segment salesAs Reported At Cutoff · USDth
MeasureFiscal 2014
Life Sciences sales1,453,6691
Industrial sales1,335,4781
USD · USDthReported values remain strings; no browser-side recalculation.
Pall six-month consolidated performanceAs Reported At Cutoff · USDth
MeasureSix months ended January 31 2014Six months ended January 31 2015
Net sales1,306,74811,370,2861
Net earnings155,1791172,6721
USD · USDthReported values remain strings; no browser-side recalculation.
Pall reported cash and debtAs Reported At Cutoff · USDth
MeasureJuly 31 2014January 31 2015
Cash and cash equivalents964,11011,029,6731
Notes payable424,9431724,7961
Long-term debt net of current portion375,8261375,3421
USD · USDthReported values remain strings; no browser-side recalculation.
Pall fiscal 2015 first-half segment economicsAs Reported At Cutoff · USDth
MeasureSix months ended January 31 2015
Life Sciences sales710,9201
Life Sciences segment profit175,3621
Industrial sales659,3661
Industrial segment profit115,1711
USD · USDthReported values remain strings; no browser-side recalculation.
Pall fiscal 2015 first-half cash allocationAs Reported At Cutoff · USDth
MeasureSix months ended January 31 2015
Operating cash flow238,1661
Acquisition of businesses net of cash acquired1,7411
Purchase of treasury stock304,1051
USD · USDthReported values remain strings; no browser-side recalculation.

Lineage

Sources available at the cutoff

5 records

Only these records were permitted inside the outcome-blind packet. Links lead to the publisher or filing archive; raw retrieved documents and excerpts are not republished here.

T1

src.danaher.cutoff.2014-10k

Danaher Corporation Form 10-K for year ended December 31, 2014

U.S. Securities and Exchange Commission · Feb 26, 2015

Regulatory FilingPrimaryContemporaneous

Used for: Cutoff-valid Danaher strategy, segment economics, cash generation and acquisition intensity · Primary description of the Danaher Business System and integration dependence

T1

src.pall.cutoff.2014-10k

Pall Corporation Form 10-K for year ended July 31, 2014

U.S. Securities and Exchange Commission · Sep 9, 2014

Regulatory FilingPrimaryContemporaneous

Used for: Cutoff-valid Pall segment, product, balance-sheet and acquisition-risk evidence · Target business-model and competitive-position reconstruction

Decision recorded?

Now test it against the outcome.

Reveal Part B